Pregnant women with hypertension who also have elevated blood uric acid levels may face an increased risk of complications that could be fatal for mother and baby, University of Pittsburgh researchers have found.
Reporting in the Oct. 27 online issue of Hypertension, a journal published by the American Heart Association, researchers note that the greatest risk of high blood pressure during pregnancy accompanies preeclampsia, a devastating disorder that affects some 5 percent of first pregnancies and is traditionally diagnosed by increased blood pressure and the presence of protein in the urine. The only effective treatment is immediate delivery, which, if too early, can pose risks to the fetus.
In developed countries where prenatal care is routine, preeclampsia accounts for about 15 percent of premature deliveries a year. Worldwide, in settings without good prenatal care, preeclampsia increases the risk of fetal death five-fold and kills 50,000 women a year, researchers said. For clinicians, treating preeclampsia is a delicate balance of fetal and maternal risk from the disease and fetal development-associated risk because of premature delivery.
Analysis of the data revealed that the women with both preeclampsia and elevated uric acid levels had a nearly seven-fold increased risk of premature delivery and delivered nearly four weeks earlier than preeclamptic women whose uric acid levels were normal. Most of these deliveries were induced to prevent more severe maternal illness and infants tended to be smaller at birth, even adjusted for gestational age, Dr. Roberts said.
One of the more interesting findings was that for women with high blood pressure and no protein in their urine but who did have increased uric acid, the risk of early delivery or reduced fetal growth was at least as likely as in women with classic signs of preeclampsia but normal uric acid. Also, women with high blood pressure who lacked urine protein and had normal uric acid had no increased risk for babies.
"Irrespective of protein levels, women with high blood pressure had a higher incidence of being delivered early as uric acid increased," said Dr. Roberts, who also is director of the university-affiliated Magee-Womens Research Institute. "For every one-unit increase in uric acid, the odds of preterm birth increased 2.3 times."
While results of the National Institutes of Health-funded study seem to suggest that uric acid measures could have a utility for predicting risk of adverse outcomes, further prospective testing is necessary to confirm the findings and determine cost-effectiveness of its use to improve outcomes, Dr. Roberts said.
In addition to Dr. Roberts, other authors are Lisa M. Bodnar, R.D., Ph.D., Kristine Yoder Lain, M.D., M.P.H., Carl A. Hubel, Ph.D., Nina Markovic, Ph.D., Roberta B. Ness, M.D., M.P.H., and Robert W. Powers, Ph.D., all of the University of Pittsburgh School of Medicine.
Michele D. Baum | EurekAlert!
Biofilm discovery suggests new way to prevent dangerous infections
23.05.2017 | University of Texas at Austin
Another reason to exercise: Burning bone fat -- a key to better bone health
19.05.2017 | University of North Carolina Health Care
The world's highest gain high power laser amplifier - by many orders of magnitude - has been developed in research led at the University of Strathclyde.
The researchers demonstrated the feasibility of using plasma to amplify short laser pulses of picojoule-level energy up to 100 millijoules, which is a 'gain'...
Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.
Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....
Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.
The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....
An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.
We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...
Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.
Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...
24.05.2017 | Event News
23.05.2017 | Event News
22.05.2017 | Event News
29.05.2017 | Earth Sciences
29.05.2017 | Life Sciences
29.05.2017 | Physics and Astronomy